Bloom Energy's 114% Rally Leaves Analysts Scrambling to Keep Up
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

Bloom Energy heads into its May 7 earnings report having more than doubled in a month — a move that has forced nearly every analyst covering the stock to rethink their numbers.
The price action is the story. Shares closed at $290.52 on Friday, up 114% in a month and 26% in the past week alone. That surge followed a 23% one-day jump after the prior earnings release on April 28, and it has left the stock trading above most revised price targets. JP Morgan lifted its target to $267 and RBC Capital moved to $335, but even that most-bullish call sits below where shares trade today. Citigroup, maintaining its Neutral rating, only just raised to $281 — still below the current price. The broad pattern: analysts are raising targets aggressively, yet the stock has already outrun the consensus mean of $230.75. The market has priced in a bullish scenario before the numbers arrive.
Options traders are more cautious than the price action implies. The put/call ratio has climbed to 1.12, more than two standard deviations above its 20-day average of 0.94, reaching the highest level of the past year. That signals heavier demand for downside protection — investors are hedging a stock that has run hard into the print, not simply adding exposure with conviction.
Short sellers are retreating, not pressing. Short interest has fallen 10% in a week to 9.1% of the float, after running near 11% earlier in April. Borrow costs remain negligible at 0.43%, and availability is loose, meaning there is no meaningful squeeze pressure fuelling the rally. The move is driven by buyers, not forced covering.
The bull case centres on data-centre demand and Bloom's expanding backlog in clean, distributed power — a theme that has driven the stock since late April. EPS momentum ranks in the 99th percentile, and forward earnings estimates have climbed sharply. Bears point to a stretched valuation: the stock trades at 104x earnings and 52x book value, and the company has issued $2.5 billion in zero-coupon convertible notes that will dilute shareholders if the price holds above roughly $185. Insiders have offered their own signal — the COO, Chief Legal Officer, and Acting CFO all sold material stakes in March and April, collectively unloading tens of millions in stock as the rally accelerated.
The May 7 print is therefore a test of whether Bloom's fundamentals can justify a valuation that its own analysts, even the most bullish, have not yet caught up to.
Against its peers
Shares moved +25.7% over the past week against a median of +18.2% for its closest peers.
Stocks in this article
See the live data behind this article on ORTEX.
Open BE on ORTEX →How this article was generated
- Generated
- 4 May 2026, 04:18
- Data as of
- 4 May 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signals
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.